Clinical Trials Browser

Burkitt Lymphoma, Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

NCT00398814 2014-02-19

Phase I Study of Perifosine + Sorafenib for Patients With Advanced Cancers

Phase 1 Completed

30 enrolled

GastrointestinalGenitourinary

Kidney Neoplasms, Liver Neoplasms, Neoplasms

NCT00399152 2014-02-19

Perifosine + Sunitinib Malate for Patients With Advanced Cancers

Phase 1 Completed

15 enrolled

Genitourinary

Kidney Neoplasms

NCT00398697 2014-02-13

Phase I Perifosine and Gemcitabine Study

Phase 1 Completed

19 enrolled

Tumor-Agnostic

Neoplasms

NCT00399087 2014-02-13

Phase I Trial of Docetaxel With Perifosine

Phase 1 Completed

39 enrolled

Tumor-Agnostic

Neoplasms

NCT00399126 2014-02-13

Phase I Trial of Paclitaxel With Perifosine

Phase 1 Completed

24 enrolled

Tumor-Agnostic

Neoplasms

NCT00301938 2013-09-30

7-Hydroxystaurosporine and Perifosine in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia or High Risk Myelodysplastic Syndromes

Phase 1 Completed

30 enrolled

LymphoidMyeloidOther hematologic neoplasm

Congenital Abnormalities, Blast Crisis, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Acute, Leukemia, Promyelocytic, Acute, Leukemia, Myelomonocytic, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Myelodysplastic-Myeloproliferative Diseases

NCT00415064 2012-07-06

Phase I Study of Perifosine + Lenalidomide and Dexamethasone for Patients With Multiple Myeloma

Phase 1 Completed

32 enrolled

Plasma cell

Multiple Myeloma

Clinical Trials

Perifosine and Torisel (Temsirolimus) for Recurrent/Progressive Malignant Gliomas

Perifosine in Treating Patients With Advanced Solid Tumors

Study of Perifosine + Capecitabine for Colon Cancer Patients

A Food Effect and QTc Study of Perifosine in Patients With Advanced Malignancies

Study of Single Agent Perifosine for Recurrent Pediatric Solid Tumors

Perifosine With Temsirolimus for Recurrent Pediatric Solid Tumors

Perifosine and Docetaxel in Patients With Relapsed Epithelial Ovarian Cancer

Perifosine in Treating Patients With Refractory Solid Tumors or Hematologic Cancer

Phase I Study of Perifosine + Sorafenib for Patients With Advanced Cancers

Perifosine + Sunitinib Malate for Patients With Advanced Cancers

Phase I Perifosine and Gemcitabine Study

Phase I Trial of Docetaxel With Perifosine

Phase I Trial of Paclitaxel With Perifosine

7-Hydroxystaurosporine and Perifosine in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia or High Risk Myelodysplastic Syndromes

Phase I Study of Perifosine + Lenalidomide and Dexamethasone for Patients With Multiple Myeloma